跳转至内容

Dear Customer:

The current international situation is complex and volatile, and uncertain tariff policies may potentially impact our product prices. Given these uncertainties, we value your understanding regarding order-related matters.

If you decide to place an order during this period, we reserve the right to adjust the price based on the evolving situation. We understand that market changes may cause inconvenience. We will negotiate with you if there’s a significant price fluctuation due to tariff policy changes before the order’s actual delivery, and in such cases we may adjust or cancel the order as necessary.

Merck
CN
  • Withanolide A and asiatic acid modulate multiple targets associated with amyloid-beta precursor protein processing and amyloid-beta protein clearance.

Withanolide A and asiatic acid modulate multiple targets associated with amyloid-beta precursor protein processing and amyloid-beta protein clearance.

Journal of natural products (2010-06-18)
Sachin P Patil, Sarah Maki, Santosh A Khedkar, Alan C Rigby, Christina Chan
摘要

Alzheimer's disease (AD) is a progressive, neurodegenerative disease histochemically characterized by extracellular deposits of amyloid beta (Abeta) protein and intracellular neurofibrillary tangles of hyperphosphorylated tau protein. AD is considered to be a complex, multifactorial syndrome, with numerous causal factors contributing to its pathogenesis. Thus, for any novel therapeutic molecule to have a "disease-modifying" effect on AD, it must be able to modulate multiple, synergistic targets simultaneously. In this context, we have studied two compounds of plant origin [withanolide A (1) and asiatic acid (2)] for their potential activities against multiple targets associated with Abeta pathways (BACE1, ADAM10, IDE, and NEP). BACE1 is a rate-limiting enzyme in the production of Abeta from amyloid-beta precursor protein (AbetaPP), while ADAM10 is involved in non-amyloidogenic processing of AbetaPP. IDE and NEP are two of the prominent enzymes involved in effectively degrading Abeta. It was found that both 1 and 2 significantly down-regulated BACE1 and also up-regulated ADAM10 in primary rat cortical neurons. In addition, 1 significantly up-regulated IDE levels, which may help in degrading excess Abeta from the AD brain. On the basis of the data obtained, the two multifunctional compounds may prove valuable in developing novel, effective therapeutics for the prevention and treatment of AD-associated amyloid pathology.

材料
货号
品牌
产品描述

Sigma-Aldrich
亚细亚酸, 97%
登录查看公司和协议定价
货号包装规格是否有货价格数量
100 mL
预计发货时间 2025年6月17日
详情...
¥569.46
500 mL
国内现货,预计发货时间 2025年4月15日
详情...
¥2,184.80
6 x 100 mL
国内现货,预计发货时间 2025年4月15日
详情...
¥2,296.95
Sigma-Aldrich
亚细亚酸, ≥98% (HPLC), from Centella asiatica
登录查看公司和协议定价
货号包装规格是否有货价格数量
100 mL
预计发货时间 2025年6月17日
详情...
¥569.46
500 mL
国内现货,预计发货时间 2025年4月15日
详情...
¥2,184.80
6 x 100 mL
国内现货,预计发货时间 2025年4月15日
详情...
¥2,296.95